Table 2 Main clinical results
Control group | Experimental group | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Time | N | Median | Mean | Sd | ∆ (sd) | Time | N | Median | Mean | Sd | ∆ (sd) | |
PD (mm) | T0 | 50 | 6 | 5.69 | 1.05 | T0 | 50 | 5.5 | 5.96 | 1.12 | ||
T1 | 44 | 5 | 5.11* | 1.73 | − 0.86 (1.25) | T1 | 44 | 5 | 5* | 1.46 | − 0.86 (0.98) | |
T2 | 44 | 4 | 4.75** | 1.67 | − 1.23 (1.34) | T2 | 44 | 5 | 4.8** | 1.5 | − 1.16 (1.34) | |
CAL (mm) | T0 | 50 | 7 | 7.38 | 1.78 | T0 | 50 | 7 | 7.28 | 1.99 | ||
T1 | 44 | 6 | 6.25* | 2.09 | − 1.02 (1.27) | T1 | 44 | 6 | 6.32* | 1.95 | − 0.79 (1.09) | |
T2 | 44 | 6 | 5.84** | 2.20 | − 1.50 (1.47) | T2 | 44 | 6 | 6.34** | 2.19 | − 0.86 (1.80) | |
VAS (mm) | T0 | 50 | 21 | 28.75§ | 23.58 | T0 | 50 | 8 | 12.56§ | 14.43 | ||
BOP | % Positive | % Positive | ||||
|---|---|---|---|---|---|---|
T0 | 50 | 90.0 | T0 | 50 | 98.0 | |
T1 | 44 | 52.3* | T1 | 44 | 59.1* | |
T2 | 44 | 52.3** | T2 | 44 | 52.3** |
Need for retreatment | % Positive | % Positive | ||||
|---|---|---|---|---|---|---|
T1 | 44 | 90.9 | T1 | 44 | 86.4 | |
T2 | 44 | 75.0 | T2 | 44 | 81.8 |